ARCHIVES

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

New Chairman Of Core Grant Review Committee Has Some Advice for Applicants

May 5, 1978

The Lancet Oncology Issues “Expression Of Concern” Over Paper

July 23, 2010

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

March 7, 2014